T 0292/20 (Combination for treating HCV patients / ABBVIE) of 13.08.2020
- European Case Law Identifier
- ECLI:EP:BA:2020:T029220.20200813
- Date of decision
- 13 August 2020
- Case number
- T 0292/20
- Petition for review of
- -
- Application number
- 14725812.3
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- COMBINATION OF DIRECT ACTING ANTIVIRAL AGENTS AND RIBAVIRIN FOR TREATING HCV PATIENTS
- Applicant name
- AbbVie Inc.
- Opponent name
- Generics (U.K.) Limited
- Board
- 3.3.01
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 113(2) (2007)
- Keywords
- Basis of decision - text or agreement to text withdrawn by patent proprietor
Basis of decision - patent revoked - Catchword
- -
- Cited cases
- T 0073/84
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.